Artificial intelligence (AI) is revolutionizing cardiovascular medicine and is on the central stage of ACC.25. This year's two-day intensive programme shows how this evolving technology can be incorporated into practice and lead to better patient care.
Intensive, co-chairman Srinath Adusalli, MD, FACC, and David Ouyang, MD, FACC, Kick-off today with a focus on “The Machine is Coming: The Fundamentals of Clinical Extension Intelligence for Clinicians”, featuring a focused presentation on the fundamentals of AI, running the most effective AI-based tools of various practice types.
In addition, John S. Rumsfeld, MD, PhD, MACC, The 56th Bishop Louis F.'s keynote address is “The past, present and future of clinical AI in cardiovascular medicine.” He highlights more recent AI milestones, including the use of machine learning, generative AI, and the large-scale use of language models, while also shedding light on new AI technologies that allow further transformation of cardiovascular care.
According to ACC Board Members Thomas M. Maddox, MD, MSC, FACC, Talking about AI generated as part of the intensive thing, AI is already used to aid in the writing of surroundings, automating pre-approval and claim processing, and acquiring and interpreting echo images. Diagnostic inference, treatment planning design, and medical education for both patients and care teams are one of the horizon applications.
“It is essential that our community understands how AI works and where its limitations lie and can be used effectively and safely to provide care,” he says. “It's no different from a community where you need to have knowledge of new medicines, medical devices and other technologies.”
Later today we will discuss practical considerations for implementing AI in practice, so that intensive things “dive into the weeds.” The session will focus on how AI is changing business models, provide opportunities for discussion on the risk of medical malpractice, and shed light on government regulations.
“The vast amount of available medical data exceeds human capabilities, so AI is needed to distill relevant information,” says ACC Chief Innovation Officer. Ami Bhatt, MD, FACC. “Clinicians need to understand AI to determine the best steps in patient care.”
Both Maddox and Bhatt hope that intensiveness will encourage clinicians to understand AI and ultimately play an active role in actually testing and implementing it. “We all need to decide where the extra help from AI will make the biggest difference and focus on those areas,” says Bhatt. “It's not always the same in every part of the country, every part of the world, every practice.”
Former President of the ACC B. Hadley Wilson, MD, MACC, Those who are also part of an intensive faculty agree. “AI is implemented at a breakneck pace in all respects,” he says. “Clinicians need to take advantage of every opportunity to get used to and cooperate with AI.” His final words of wisdom: “Wait for the Wild Ride.”
keyword:
Heart disease magazine, ACC Publications, artificial intelligence, ACC Annual Science Session, ACC25
